Advanced Enzyme Technologies Limited — Others, 31-07-2025: Shareholders meeting

Advanced Enzyme Technologies Limited's 36th Annual General Meeting saw shareholders approve all proposed resolutions. This included adopting the financial statements for the year ended March 31, 2025, and approving a final dividend of Rs. 1.20 per equity share. Shareholders also re-appointed Mr. Mukund Kabra as a Director and appointed Mr. Shiv Hari Jalan as Secretarial Auditor for five years. Additionally, a resolution for related party transactions with subsidiary JC Biotech Private Limited was passed, with relevant votes excluded to ensure fair corporate governance. This confirms crucial operational and financial approvals for the company.